Cite

HARVARD Citation

    Gkanti, V. et al. (2023). Drug survival of brodalumab is greater in patients with psoriasis and psoriatic arthritis in a real‐world setting. International journal of dermatology. pp. e31-e34. [Online]. 
  
Back to record